Abeona Therapeutics Inc Warrant
ABEOW
ABEOW was delisted on the 20th of December, 2019.
4 hedge funds and large institutions have $2.06M invested in Abeona Therapeutics Inc Warrant in 2018 Q4 according to their latest regulatory filings, with funds opening new positions, increasing their positions, 1 reducing their positions, and 1 closing their positions.
20% less funds holding
Funds holding: 5 → 4 (-1)
73% less capital invested
Capital invested by funds: $7.49M → $2.06M (-$5.44M)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 1
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 1
Top Buyers
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
OFG
OTA Financial Group
Purchase,
New York
|
-$360K |
| 2 |
UBS Group
Zurich,
Switzerland
|
-$1.35K |
ABEOW Hedge Fund Activity: Q4 2018 in Review
4 of the 4,489 institutional investors tracked by Wall St. Rank reported a position in Abeona Therapeutics Inc Warrant (ABEOW) for Q4 2018, worth a combined $2.06M — down 73% from $7.49M a quarter earlier.
Sellers outnumbered buyers: 1 fund closed out of ABEOW and 0 opened new positions — a net loss of 1 holder — while 1 trimmed existing stakes and 0 added.
The largest seller was OTA Financial Group, exiting entirely with an estimated $360K sold.
- 4 institutional investors held Abeona Therapeutics Inc Warrant (ABEOW) as of Q4 2018, down from 5 in Q3 2018.
- Funds reported $2.06M of Abeona Therapeutics Inc Warrant stock for Q4 2018, down 73% quarter-over-quarter.
- 0 funds opened new Abeona Therapeutics Inc Warrant positions in Q4 2018 and 1 closed out, a net change of -1 holder.
- The largest Abeona Therapeutics Inc Warrant seller in Q4 2018 was OTA Financial Group, an estimated $360K sold.
Based on aggregated 13F filings for Q4 2018.